Longevity Biomedical Inc LBIO
Trading Information
- Previous Close Price
- —
- Day Range
- —–—
- 52-Week Range
- —–—
- Bid/Ask
- — / —
- Market Cap
- —
- Volume/Avg
- — / —
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Longevity Biomedical Inc is a clinical-stage biomedical company. The company is focused on the advancement of new technologies across therapeutics, monitoring, and digital health that aim to restore tissue form and function to increase health span. Longevity is acquiring a differentiated therapeutic pipeline of late-stage clinical technologies across ophthalmology, cardiovascular disease, and soft tissue reconstruction and repair.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- —
- Total Number of Employees
- —
Valuation
|
Metric
|
LBIO
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | — |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
LBIO
|
|---|---|
Quick Ratio | — |
Current Ratio | — |
Interest Coverage | — |
Quick Ratio
No chart available
Profitability
|
Metric
|
LBIO
|
|---|---|
Return on Assets (Normalized) | — |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | — |
Return on Assets
No chart available
Biotechnology Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
NVO
| Novo Nordisk A/S ADR | Jzlprwkzdn | Brjmd | $554.7 Bil | |
VRTX
| Vertex Pharmaceuticals Inc | Bgkgjtrf | Wbjfrf | $102.7 Bil | |
REGN
| Regeneron Pharmaceuticals Inc | Sxwxdkzd | Jwbnl | $97.8 Bil | |
MRNA
| Moderna Inc | Nrtchrwh | Vvs | $41.3 Bil | |
ARGX
| argenx SE ADR | Wntldfyz | Fntnh | $22.3 Bil | |
BNTX
| BioNTech SE ADR | Tghwtbkmn | Myvnk | $21.0 Bil | |
ALNY
| Alnylam Pharmaceuticals Inc | Lktcvpdv | Zrysmvy | $18.2 Bil | |
BMRN
| Biomarin Pharmaceutical Inc | Vdmkwwpv | Fwfsr | $15.4 Bil | |
RPRX
| Royalty Pharma PLC Class A | Fmwyqcykdv | Rypqhn | $12.5 Bil | |
INCY
| Incyte Corp | Lmdbtwxd | Cmqnsm | $11.6 Bil |